ArticleDiscover oncology2025
Identification of intracranial solitary fibrous tumor and atypical meningioma by multi-parameter MRI-based radiomics model.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sellar Solitary Fibrous Tumor Mimicking Pituitary Adenoma: Diagnostic Pitfalls, Contemporary Pathological Classification, and Management Considerations.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposesThe preoperative distinction between atypical meningioma (AM) and intracranial solitary fibrous tumor (SFT) holds significant importance in guiding surgical approach decisions and prognostic assessments.
methodsA total of 310 SFT patients and 203 AM patients were retrospectively included and stratified into training and validation cohorts. Employing the elastic net algorithm, relevant features were identified to form the fusion radiomic model. Subsequently, a clinical-radiomic combined model was developed by integrating the fusion radiomic model with significant clinical variables through multivariate logistic regression analysis. The models' calibration, discriminative capacity, and clinical utility were thoroughly assessed.
resultsThe fusion radiomic model was crafted from 17 radiomic features, achieving AUC values of 0.920 in the training set and 0.870 in the validation set. Subsequently, the clinical-radiomic combined model exhibited AUC values of 0.930 and 0.890 in the training and validation sets, indicating commendable discrimination and calibration. Assessment through decision curve analysis underscored the clinical utility of both the fusion radiomic model and the clinical-radiomic combined model for individuals with intracranial SFT and AM.
conclusionsThe clinical-radiomic combined model exhibited notable sensitivity and exceptional efficacy in the distinctive diagnosis of intracranial SFT and AM, holding promise for the non-invasive advancement of personalized diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.